Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors
- 1 February 2000
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 14 (3), 235-236
- https://doi.org/10.1097/00002030-200002180-00004
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitorsAIDS, 2000
- Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitorsAIDS, 1999
- Interactions of HIV Protease Inhibitors with ATP-Dependent Drug Export ProteinsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,1999
- Reactive oxygen species participate in mdr1b mRNA and P-glycoprotein overexpression in primary rat hepatocyte culturesCarcinogenesis: Integrative Cancer Research, 1999
- P-170 glycoprotein (P-170) is involved in the impairment of natural killer cell-mediated cytotoxicity in HIV+ patientsImmunology Letters, 1995